semaglutide microdosing for inflammation GLP-1: A Next-Generation Approach to Metabolic and Longevity Medicine: Shamsah Amersi, MD: OB-GYNs Microdose GLP-1 for Women -

Waiting until your last pen to reorder introduces pressure that is entirely avoidable

Our GLP-1 agonist therapies, Semaglutide and Tirzepatide for weight loss, offer a proven path to lasting weight loss

These included gastrointestinal lesions, pancreatic injury, hepatic damage, cardiac tissue impairment, endothelial disruption, and alterations in vascular pressure regulation

Protects muscle mass and bone density during rapid weight loss

May not be appropriate when Certain medical histories, conditions, medications, or personal circumstances mean a GLP-1 or GIP therapy isnt safe or suitable or calls for extra caution